Social Media
Support Arthritis & Osteoporosis NSW’s world record attempt for the “Largest Gathering of Skeletons” this Halloween – September 22, 2015
Join Arthritis & Osteoporosis NSW for it’s quirky Our Joint event in Sydney to mark Halloween on Friday, October 30, 2015 from 4-9pm. To help raise awareness of bone and joint health, and support the one-in-five Australians living with arthritis, osteoporosis, or more than 120 musculoskeletal diseases, head to Dudley Page Reserve at Dover Heights, Sydney…
Read MorePharmacy profession remains buoyant – September 17, 2015
The pharmacy profession is continuing to grow, with 29,014 registered pharmacists nation-wide, according to the most recent (June, 2015) Pharmacy Board of Australia figures. The latest stats reveal there are 26,179 general pharmacist registrations; 1,815 provisional registrations; 14 limited registrations and 1,006 on-practising registrations. Pharmacist numbers have increased by 97, from 28,853 registered practitioners in…
Read MoreCurbing future weight gain among kids with milk, not water: new University of Sydney research – September 17, 2015
University of Sydney researchers cite daily consumption of fruit juice and soft drinks among obese-prone two-to-six year olds places them at risk of becoming overweight. The 18 month long study just published in The British Journal of Nutrition confirms children predisposed to weight gain should avoid sugar-laden drinks, and substitute milk for water in order…
Read MoreOne-in-two Australians affected by chronic disease: AIHW report – August 14, 2015
New figures released by the Australian Institute of Health and Wellness (AIHW) this week (Wednesday, August 12, 2015) reveal 50 per cent of Aussies are living with at least one chronic disease, while 20 per cent of us are battling two or more chronic diseases. Among people aged 45 and older, this figure doubles to…
Read MoreA mother’s renewed appeal to the government to save her young daughter’s life – July 31, 2015
On December 1, 2014, the small aHUS Australian community celebrated with the PBS listing of Soliris (eculizumab) through Section 100: Highly Specialised Drugs Program for those who meet certain criteria, and the earmarking of $63 million in treatment funding over the next four years. Since then, our celebrations have begun to sour, as aHUS patients currently accessing…
Read More